Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Dipeptidyl Peptidase-4 Inhibitor Protects Against Tacrolimus-induced Diabetes by Decreasing Oxidative Stress
저자 Long Jin, Shang Guo Piao, Kyoung Chan Doh, Sun Woo Lim, Jian Jin, Seong Beom Heo, Byung Ha Chung, Chul Woo Yang
출판정보 2013; 2013(1):
키워드 Tacrolimus, Sitagliptin, 췌장
초록 Background: Tacrolimus(TAC)-induced diabetes mellitus is one of the important causes of post-transplant diabetes mellitus. This study was performed to evaluate the effect of DPP-4 inhibitor; sitagliptin (STGL) on pancreatic injury caused by TAC. Method: TAC (1mg/kg/day, SC) with or without STGL (10, 20, 40 mg/kg/day, gavage) were administered to rats for 4 weeks. Body weight and water intake were measured every week. The effect of STGL on TAC-induced pancreatic injury was evaluated by intraperitoneal glucose tolerance test (IPGTT), serum insulin level, and islet size. Area under the curve for glucose (AUCg) was calculated by trapezoidal estimation from the values obtained during the IPGTT, and islet size was measured with insulin-positive area. Oxidative stress was evaluated by measuring serum 8-hydroxy-2’-deoxyguanosine (8-OHdG) level. Results: After four weeks, co-treatment with STGL was recovered body weight compared with TAC alone. Water intake was increased in TAC group, but addition of STGL decreased water intake volume. TAC treatment significantly increased area under the curve for glucose (AUCg) (TAC+S10: 459.2±25; TAC+S20: 392.7±33 vs. TAC: 534.7±25 mg/dL.min; p<0.05), but STGL co-treatment recovered these values compared with the TAC alone. Decreased serum insulin level by TAC treatment was significantly increased when combined with STGL20, 40 (TAC+S20:0.44±0.05; TAC+S40:0.44±0.03 vs.TAC:0.29±0.03 ng/mL; p<0.05). Islet size was significantly decreased in TAC group, but it was recovered when it combined with STGL40 (TAC+S40:5631.6±1384.6 vs. TAC: 3910.3±626.4 UM; p<0.05). Addition of STGL (10or20) on TAC was significantly reduced serum 8-OHdG level compared with TAC alone (TAC+S10: 0.40±0.22; TAC+S20:0.49±0.09vs. TAC:0.80±0.12 ng/mL p<0.05). Conclusion: DPP-4 inhibitor has a protective effect on Tacrolimus-induced diabetes by decreasing TAC-induced oxidative stress.
원문(PDF) PDF 원문보기
위로가기